These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10486655)

  • 1. [A new cause of resistant arterial hypertension: coprescription with anticonvulsant treatments].
    Iaria P; Blacher J; Asplanato M; Edric K; Safar M; Girerd X
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1005-8. PubMed ID: 10486655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Refractory arterial hypertension and the use of anticonvulsant drugs. Case report].
    Downey P; Fajuri A; Valdés G
    Rev Med Chil; 2001 Nov; 129(11):1325-7. PubMed ID: 11836887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced refractory arterial hypertension].
    Frangos Lordos E; Trombert V; Kuzmanovic I; Vogt-Ferrier N; Perrenoud JJ
    Rev Med Suisse; 2005 Nov; 1(39):2522, 2525-6. PubMed ID: 16323733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nimodipine, a dihydropyridine calcium channel antagonist on the pharmacokinetics of carbamazepine in rhesus monkeys.
    Gupta MC; Garg SK; Das BP; Bhargava VK
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):347-51. PubMed ID: 14723323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension].
    Benvenuti C; Guerini Rocco C; Trezzi P
    Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicardipine in combination with other antihypertensive drugs: calcium antagonist and prazosin have no additive antihypertensive effect?
    Kanniainen E; Lilja M; Juustila H; Pasanen A; Jounela AJ
    Cor Vasa; 1990; 32(2):126-33. PubMed ID: 2350966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
    Guo QH; Pan CY; Qi WH; Lin SY;
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
    Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience with isradipine for the treatment of hypertension in children.
    Strauser LM; Groshong T; Tobias JD
    South Med J; 2000 Mar; 93(3):287-93. PubMed ID: 10728516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial hypertension: second-line treatment. Try other single-agent treatments.
    Prescrire Int; 2008 Jun; 17(95):115-8. PubMed ID: 18630388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between a bid and a tid regimen: improved compliance with no improved antihypertensive effect. The EOL Research Group.
    Boissel JP; Meillard O; Perrin-Fayolle E; Ducruet T; Alamercery Y; Sassano P; Benghozi R
    Eur J Clin Pharmacol; 1996; 50(1-2):63-7. PubMed ID: 8739813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of nicardipine in 29,104 patients with hypertension.
    Dubois C; Blanchard D
    Clin Ther; 1989; 11(4):452-60. PubMed ID: 2673515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
    Kenyon KW
    Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension emergencies].
    Baccar H; Bezdah L; Ouechtati W; Kasri R
    Tunis Med; 2000 Jan; 78(1):14-23. PubMed ID: 10894031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.